SectorPharmaceutical
Established Date--
Listing Date15/09/2025
ExchangeNASDAQ Stock Exchange
Full-time Employees8
Fiscal Year Ends31/12
Security TypeCommon stock
Office address611 Gateway Boulevard, Suite 740, South San Francisco, California 94080
Business
IntroductionSpruce Biosciences, Inc., was originally incorporated as a limited liability company in Delaware in November 2014. The company is a late-stage biopharmaceutical company focused on developing and commercializing new therapies for rare endocrine diseases with unmet medical needs. The company is initially developing a wholly-owned product candidate, tildacerfont, as a potential first non-steroidal therapy to provide significantly improved disease control and reduced steroid burden for patients with typical congenital adrenal hyperplasia.
